Literature DB >> 19438721

Enzymatic investigation of the Staphylococcus aureus type I signal peptidase SpsB - implications for the search for novel antibiotics.

Smitha Rao1, Katrijn Bockstael, Sangeeta Nath, Yves Engelborghs, Jozef Anné, Nick Geukens.   

Abstract

Staphylococcus aureus has one essential type I signal peptidase (SPase), SpsB, which has emerged as a potential target in the search for antibiotics with a new mode of action. In this framework, the biochemical properties of SpsB are described and compared with other previously characterized SPases. Two different substrates have been used to assess the in vitro processing activity of SpsB: (a) a native preprotein substrate immunodominant staphylococcal antigen A and (b) an intramolecularly quenched fluorogenic synthetic peptide based on the sequence of the SceD preprotein of Staphylococcus epidermidis for fluorescence resonance energy transfer-based analysis. Activity testing at different pH showed that the enzyme has an optimum pH of approximately 8. The pH-rate profile revealed apparent pK(a) values of 6.6 and 8.7. Similar to the other SPases, SpsB undergoes self-cleavage and, although the catalytic serine is retained in the self-cleavage product, a very low residual enzymatic activity remained. In contrast, a truncated derivative of SpsB, which was nine amino acids longer at the N-terminus compared to the self-cleavage product, retained activity. The specificity constants (k(cat)/K(m)) of the full-length and the truncated derivative were 1.85 +/- 0.13 x 10(3) m(-1).s(-1) and 59.4 +/- 6.4 m(-1).s(-1), respectively, as determined using the fluorogenic synthetic peptide substrate. These observations highlight the importance of the amino acids in the transmembrane segment and also those preceding the catalytic serine in the sequence of SpsB. Interestingly, we also found that the activity of the truncated SpsB increased in the presence of a non-ionic detergent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438721     DOI: 10.1111/j.1742-4658.2009.07037.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  10 in total

1.  Type I signal peptidase and protein secretion in Staphylococcus epidermidis.

Authors:  Michael E Powers; Peter A Smith; Tucker C Roberts; Bruce J Fowler; Charles C King; Sunia A Trauger; Gary Siuzdak; Floyd E Romesberg
Journal:  J Bacteriol       Date:  2010-11-12       Impact factor: 3.490

2.  Reconstitution of Staphylococcus aureus Lipoteichoic Acid Synthase Activity Identifies Congo Red as a Selective Inhibitor.

Authors:  Christopher R Vickery; B McKay Wood; Heidi G Morris; Richard Losick; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2018-01-09       Impact factor: 15.419

3.  Pseudomonas aeruginosa possesses two putative type I signal peptidases, LepB and PA1303, each with distinct roles in physiology and virulence.

Authors:  Richard D Waite; Ruth S Rose; Minnie Rangarajan; Joseph Aduse-Opoku; Ahmed Hashim; Michael A Curtis
Journal:  J Bacteriol       Date:  2012-06-22       Impact factor: 3.490

4.  Comparative Target Analysis of Chlorinated Biphenyl Antimicrobials Highlights MenG as a Molecular Target of Triclocarban.

Authors:  Robert Macsics; Mathias W Hackl; Christian Fetzer; Dietrich Mostert; Jennifer Bender; Franziska Layer; Stephan A Sieber
Journal:  Appl Environ Microbiol       Date:  2020-08-03       Impact factor: 4.792

Review 5.  Overcoming resistance to β-lactam antibiotics.

Authors:  Roberta J Worthington; Christian Melander
Journal:  J Org Chem       Date:  2013-03-28       Impact factor: 4.354

6.  Activatable Optical Probes for the Detection of Enzymes.

Authors:  Christopher R Drake; David C Miller; Ella F Jones
Journal:  Curr Org Synth       Date:  2011-08       Impact factor: 1.975

7.  A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase.

Authors:  Shilah A Bonnett; Juliane Ollinger; Susantha Chandrasekera; Stephanie Florio; Theresa O'Malley; Megan Files; Jo-Ann Jee; James Ahn; Allen Casey; Yulia Ovechkina; David Roberts; Aaron Korkegian; Tanya Parish
Journal:  ACS Infect Dis       Date:  2016-09-19       Impact factor: 5.084

8.  Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms.

Authors:  Philipp Le; Elena Kunold; Robert Macsics; Katharina Rox; Megan C Jennings; Ilke Ugur; Maria Reinecke; Diego Chaves-Moreno; Mathias W Hackl; Christian Fetzer; Franziska A M Mandl; Johannes Lehmann; Vadim S Korotkov; Stephan M Hacker; Bernhard Kuster; Iris Antes; Dietmar H Pieper; Manfred Rohde; William M Wuest; Eva Medina; Stephan A Sieber
Journal:  Nat Chem       Date:  2019-12-16       Impact factor: 24.427

9.  Harnessing the power of transposon mutagenesis for antibacterial target identification and evaluation.

Authors:  Timothy C Meredith; Hao Wang; Patrick Beaulieu; Angelika Gründling; Terry Roemer
Journal:  Mob Genet Elements       Date:  2012-07-01

10.  A Kayvirus Distant Homolog of Staphylococcal Virulence Determinants and VISA Biomarker Is a Phage Lytic Enzyme.

Authors:  Aleksandra Głowacka-Rutkowska; Magdalena Ulatowska; Joanna Empel; Magdalena Kowalczyk; Jakub Boreczek; Małgorzata Łobocka
Journal:  Viruses       Date:  2020-03-07       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.